Cargando…
Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276550/ https://www.ncbi.nlm.nih.gov/pubmed/35013779 http://dx.doi.org/10.1007/s00520-021-06700-0 |
| _version_ | 1784745754700546048 |
|---|---|
| author | Peipert, John Devin Smith, Mary Lou |
| author_facet | Peipert, John Devin Smith, Mary Lou |
| author_sort | Peipert, John Devin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9276550 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92765502022-07-14 Reconsidering tolerability of cancer treatments: opportunities to focus on the patient Peipert, John Devin Smith, Mary Lou Support Care Cancer Commentary Springer Berlin Heidelberg 2022-01-11 2022 /pmc/articles/PMC9276550/ /pubmed/35013779 http://dx.doi.org/10.1007/s00520-021-06700-0 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Commentary Peipert, John Devin Smith, Mary Lou Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title | Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title_full | Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title_fullStr | Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title_full_unstemmed | Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title_short | Reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| title_sort | reconsidering tolerability of cancer treatments: opportunities to focus on the patient |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276550/ https://www.ncbi.nlm.nih.gov/pubmed/35013779 http://dx.doi.org/10.1007/s00520-021-06700-0 |
| work_keys_str_mv | AT peipertjohndevin reconsideringtolerabilityofcancertreatmentsopportunitiestofocusonthepatient AT smithmarylou reconsideringtolerabilityofcancertreatmentsopportunitiestofocusonthepatient AT reconsideringtolerabilityofcancertreatmentsopportunitiestofocusonthepatient |